Physician Payments & Other Transfers of Value
We’re guided by openness and transparency in our relationships with health care providers (HCPs), health care organizations (HCOs), and patient organizations.
We Believe Interactions with Health Care Professionals Bring Value to Patient Care
AbbVie is committed to collaborating with health care professionals (HCPs), health care organizations (HCOs) and patient organizations to improve patient health across the globe. Our interactions with HCPs, HCOs and patient organizations are guided by openness and transparency to ensure public trust and confidence. AbbVie supports disclosure of these relationships wherever possible to demonstrate the integrity of our relationships with HCPs, HCOs and patient organizations.
HCP/HCO Disclosures Inside the US
Open Payments—Physician Payments Sunshine Act
The US Sunshine Act, also known as the Open Payments—Physician Payments Sunshine Act, was enacted as federal law in 2010 as a component of the Affordable Care Act. The Act requires health care manufacturers, including AbbVie, to track financial transactions with certain health care providers and health care organizations (HCOs) and to disclose those transactions on an annual basis. We support the Act and its goal of providing the public greater visibility into interactions between the health care industry and HCPs to ensure public trust and confidence. To learn more, view our FAQs.
Report information
The report is based on transactional data that has been aggregated at a particular point in time; some payments and transfers of value that take place during the reporting period may be included in the next quarter’s report. Posted data may not correlate to state transparency reports due to differences in the scope and requirements between the various transparency laws. Changes or additions that are identified after the report is posted will be accounted for in the next quarter’s report. Due to the requirements for reporting related entities/payees, some payments shown on the report are included more than once. The types of payments and transfers of value included in the report are as follows:
- Business Meals, which include reimbursed amounts for meals incurred in the course of providing contracted-for services such as consulting and research; and meals provided in connection with an educational or business discussion
- Business Travel, which includes reimbursed amounts and the value of directly provided transportation (e.g., airfare, taxi service) incurred in the course of providing contracted-for services such as consulting and research
- Educational Materials and Items, which include reference materials such as journal articles, textbooks and anatomical models
- Professional Services, which include payments for contracted-for services such as speaking at an educational seminar or serving on a data safety monitoring board
- Research-Related Payments, which include payments for research and clinical trial activities, royalties and license fees
- Job Interview-related payments, such as flights, meals, hotel, area tours, etc. Your collected information will only be released on the public website if you are selected to interview and have expenses paid for or reimbursed to you by AbbVie. Additionally, Massachusetts and Vermont have expanded rulings that require interview-related expenses to be reported for “Health Care Providers & Practitioners.” Expenses incurred during the interview process may be reported under the Federal Sunshine Act (and other State laws).
For Physician Payment Reports, AbbVie follows the annual de minimis threshold reporting guidance as provided by CMS for Open Payments reporting.
Related Reports
2016 Annual Physician Payment Report
2016 Annual Supplemental Report – Indirect Research Payments Made to Entities
2015 Annual Physician Payment Report
2015 Annual Supplemental Report – Indirect Research Payments Made to Entities
2014 Annual Physician Payment Report
2014 Annual Supplemental Report – Indirect Research Payments Made to Entities
2013 Annual Physician Payment Report
2012 Annual Physician Payment Report (July 1–December 31)
If you have questions on the data contained in the reports, please email TransparencyReporting@abbvie.com.
HCP/HCO Disclosures Outside of the US
Information exchanged with Healthcare Professionals (HCPs), Healthcare Organizations (HCOs) and patient organizations has led to newer and better therapies and, most importantly, enhanced care for patients. We believe collaboration with HCPs, HCOs and patient organizations bring value to patient care that have delivered numerous innovative medicines and changed the way diseases impact our lives. Our interactions with them are guided by openness and transparency, with a goal of providing the public with greater visibility into these interactions to ensure public trust and confidence. AbbVie engages in a range of activities from clinical research to sponsorships to educational activities to exchange information on how new medicines fit into the patient pathway. By bringing greater transparency to these relationships, AbbVie demonstrates its ongoing commitment to strengthening the basis for future collaboration.
Australia – Disclosure Data
Japan – Disclosure Data
AbbVie strongly supports the need for more transparency throughout our industry. It is a cornerstone of the pact of trust we have with patients and society as a whole. As such, AbbVie fully supports the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code on Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals (HCPs) and Healthcare Organizations (HCOs). We are therefore proud to be disclosing for the second year, our data on transfers of value to HCPs and HCOs in Europe.
In addition, AbbVie has annually published data regarding the financial support we provide to European Patient Organizations since 2008.
Austria
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Belgium
2015 – Disclosure Data
2016 – Disclosure Data
Bulgaria
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Croatia
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Cyprus
2015 – Disclosure Report , Additional Document
2016 – Disclosure Report , Additional Document
Czech Republic
2015 – Disclosure Data
2016 – Disclosure Data
Estonia
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Finland
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
France
2015 – Disclosure Data
2016 – Disclosure Data
Germany
2015 – Discloure Report, Additional Document
2016 – Discloure Report, Additional Document
Greece
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Hungary
2015 – Disclosure Report , Additional Document
2016 – Disclosure Report , Additional Document
Iceland
2015 – Disclosure Data
2016 – Disclosure Data
Ireland
2015 – Disclosure Data
2016 – Disclosure Data
Italy
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Latvia
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Lithuania
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Luxembourg
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Malta
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Netherlands
2015 – Disclosure Data
2016 – Disclosure Data
Norway
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Poland
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Portugal
2015 – Disclosure Data*
2016 – Disclosure Data*
*Please use Google Chrome to view this link.
Romania
2015 – Disclosure Data
2016 – Disclosure Data
Russia
2015 – Disclosure Data
2016 – Disclosure Data
Serbia
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Slovakia
2015 – Disclosure Report, Additional Document
2016 – MoH Disclosure Data
2016 – AIFP Disclosure Report, AIFP Additional Document
Slovenia
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Spain
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Sweden
2015 – Disclosure Data
2016 – Disclosure Data
Switzerland
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
Turkey – Pending Local Clarification
Ukraine
2015 – Disclosure Report, Additional Document
2016 – Disclosure Report, Additional Document
United Kingdom
2015 – Disclosure Data
2016 – Disclosure Data
European Patient Organization Relationships
AbbVie is committed to making a remarkable impact on patients’ lives and their caregivers. We pursue learning about patient experiences to understand their issues, concerns and priorities.
Patient organizations are a source of valuable information and support for patients and their caregivers. We foster patient organization relationships based on mutual trust, respect and patient-centric goals that reflect AbbVie’s transparent, highly ethical behavioral standards. Through these relationships, AbbVie helps educate patients and caregivers about disease states, treatment options and how to improve quality of life. These partnerships facilitate patient-centric dialogue between interested parties and help create new, cost-effective health care delivery models.
Annually, AbbVie publishes a list of its financial suppotrt of European Patient Organizations. Our publication of the following report demonstrates our commitment to transparent disclosure of our financial relationships with patient organizations.
AbbVie’s 2016 European Patient Organization Report
*Please note that a few European countries are excluded in this list as they are required to follow national disclosure procedures and timelines.
Serbia - Sponsored Professional Conferences
AbbVie has a long-standing commitment to supporting programs aimed at increasing the understanding of scientific, clinical and health care issues that improve patient care. In the interest of transparency, we are disclosing the following list of professional conferences sponsored by AbbVie.
Sponsored Professional Conferences 2013
Sponsored Professional Conferences 2014
Sponsored Professional Conferences 2015